The Role of Transpapillary Stenting in the Treatment of Bile Leakage After Liver Transection.
NCT ID: NCT01960712
Last Updated: 2020-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2008-11-30
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endoscopic Treatment of Benign Biliary Strictures and Cystic Duct Leakages With a Novel Biodegradable Biliary Stent
NCT02353286
Endoscopic Stenting Across the Papilla Versus the Leak Site to Treat Bile Leak
NCT03103139
Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail
NCT00500968
Biodegradable Biliary Stent for Post Operative Cystic Duct Leakage
NCT00493675
Preoperative Stent Study
NCT00501176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continued external drainage
Continued external drainage alone.
No interventions assigned to this group
Continued external drainage + transpapillary stent
External drainage + transpapillary plastic stent (7-10 Fr).
Transpapillary plastic stent (7-10 Fr)
Duodenoscopy plus transpapillary bile cannulation plus stent insertion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transpapillary plastic stent (7-10 Fr)
Duodenoscopy plus transpapillary bile cannulation plus stent insertion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jansson, Anders, M.D.
INDIV
Karolinska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Lundell
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Lundell, Professor
Role: PRINCIPAL_INVESTIGATOR
Karolinska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska University Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2006/1142-31/3
Identifier Type: OTHER
Identifier Source: secondary_id
2006/1142-31/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.